AstraZeneca reports ‘historic’ trial results for Enhertu cancer treatment

The pharmaceutical companies said Enhertu demonstrated meaningful survival improvement in patients with breast cancer compared with physician's choice of chemotherapy.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.